DIFFERIN (adapalene) Galderma labs lp Patent: 8,703,820 Expiration: Mar 12, 2023 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of March 12, 2023 Read Post »
Annual Drug Patent Expirations for DIFFERIN Differin is a drug marketed by Galderma Labs Lp and is included in five
New patent expiration for Galderma Labs drug DIFFERIN Read Post »
Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It
Annual Drug Patent Expirations for SUPREP+BOWEL+PREP+KIT Suprep Bowel Prep Kit is a drug marketed by Braintree Labs and is included
New patent expiration for Braintree Labs drug SUPREP BOWEL PREP KIT Read Post »
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA.
New patent expiration for Evofem Inc drug PHEXXI Read Post »
Annual Drug Patent Expirations for BINOSTO Binosto is a drug marketed by Ascend Theraps Us and is included in one
New patent expiration for Ascend Theraps drug BINOSTO Read Post »
Annual Drug Patent Expirations for NORMOCARB+HF+25 Normocarb Hf 25 is a drug marketed by Dialysis Sups and is included in
New patent expiration for Dialysis Sups drug NORMOCARB HF 25 Read Post »
Annual Drug Patent Expirations for ZOLINZA Zolinza is a drug marketed by Msd Sub Merck and is included in one
ZOLINZA (vorinostat) Msd sub merck Patent: 8,067,472 Expiration: Mar 4, 2023 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 26, 2023 Read Post »
Get fresh news and insights, drug patent expirations & more…
